Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Wei Shi, Jeff Bruce, Matthew Lee, Shijun Yue, Matthew Rowe, Melania Pintilie, Ryunosuke Kogo, Pierre-Antoine Bissey, Anthony Fyles, Kenneth W. Yip, Fei-Fei Liu
Published Feb 26, 2016 · Vol. 7, No. 14 · pp. 18906-18918
Peng Gao, Chunzhang Yang, Cody L. Nesvick, Michael J. Feldman, Saman Sizdahkhani, Huailei Liu, Huiying Chu, Fengxu Yang, Ling Tang, Jing Tian, Shiguang Zhao, Guohui Li, John D. Heiss, Yang Liu, Zhengping Zhuang, Guowang Xu
Published Feb 25, 2016 · Vol. 7, No. 12 · pp. 15200-15214
Robert Fred Henry Walter, Claudia Vollbrecht, Robert Werner, Jeremias Wohlschlaeger, Daniel Christian Christoph, Kurt Werner Schmid, Fabian Dominik Mairinger
Published Feb 24, 2016 · Vol. 7, No. 14 · pp. 18713-18721